Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$45.2M
2 rounds on record
Latest round
$37.8M
Series C · Apr 2025 · 17 mo ago
Backers
1
Asabys Partners
The money's age
Due for its next round
17 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jan 22 Recognition SafeHeal Named to LSI's Q1 2026 "Hot 25" MedTech Startups List · safeheal.com Jul 11, 2022 New executive SafeHeal appoints medical device industry veteran Chris Richardson as Chief Executive Officer · safeheal.com
Funding rounds
RoundDateAmountInvestorsSource
Series C Apr 2025 $37.8M — businesswire.com
Series A Mar 2018 $7.4M — fiercebiotech.com
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
VesteckVenture round $354k · 11 mo ago • Founded 2019 • 51-200 employees
Vesteck Inc. is a clinical stage medical device company, developing a platform for securing endovascular aortic repair grafts (EVAR/TEVAR)…
CreaternaSeries A · 3 yr ago
Createrna is an innovative drug research and development company in the clinical stage.
The Medical Device Business Journal — Medical Device News & Articles | MassDevice.
VenoStentSeries A $16.1M · 3 yr ago • Founded 2017
Patients & Providers How SelfWrap Works Company News Clinical Trial Follow us for updates: LinkedIn Aiming to Improve the Lives of Patients…
Pincelli is a pre-clinical stage biotech company focused on the development of innovative first-in-class treatments for rare skin diseases.
Medical Device Developmentto Enhance the Quality of Life. 再生医療機器開発.

Overview

SafeHeal is a clinical stage medical device manufacturer focusing on the development of anastomosis protection devices, including Colovac, for colorectal surgery.

News

Blog 5 months ago
WATCH: NBC10 Philadelphia Spotlights SAFE-3CV Study and Potential Improved Recovery Outcomes for Colorectal Cancer Patients
Through the story of one colorectal cancer patient, the news feature highlights the SAFE-3CV clinical study, which has the potential to improve recovery and quality of life after colorectal surgery. NBC10 Philadelphia recently featured a powerful patient
Read more
Report
Award 9 months ago
SafeHeal Named to LSI's Q1 2026 "Hot 25" MedTech Startups List
January 22, 2026 - SafeHeal is proud to announce its inclusion in Life Science Intelligence's (LSI) Q1 Hot 25 MedTech Startups list. This prestigious ranking recognizes the "hottest" medtech companies entering 2026 based on innovation, market potential, a
Read more
Report
Blog 9 months ago
SafeHeal Announces Successful Launch of SAFE-3CV IDE Study for Colovac Anastomosis Protection Technology
Breakthrough device promises significantly improved patient recovery after colorectal surgery January 12, 2026 - SafeHeal, a leading innovator in the field of colorectal cancer surgery, today announced the first patient enrollment in its pivotal IDE study
Read more
Report
Blog 12 months ago
SafeHeal's Jenny Gaffney to Address Medicare Reimbursement at The MedTech Conference 2025
October 6, 2025 - Jenny Gaffney, Vice President of Healthcare Economics & Reimbursement, will serve as a featured panelist at The MedTech Conference 2025, hosted by AdvaMed in San Diego. Gaffney will lend her expertise to a timely discussion on reimbursem
Read more
Report
Press release The Manila Times 1 year ago
Asabys Partners Leads €10 Million Extension of SafeHeal's Oversubscribed Series C Financing to Accelerate Commercialization of Colovac
Asabys joins SafeHeal's global investor syndicate, which includes Sofinnova, Solar Eclipse and a Leading Multinational Life Sciences Corporation, bringing additional resources and strategic expertise to advance pivotal U.S. trial and commercial launch of
Read more
Report
Blog 1 year ago
SafeHeal Receives European Marketing Approval Under MDR for Colovac Anastomosis Protection Technology
Marketing approval allows imminent commercialization of the Colovac device in key EU markets PARIS, France/Tampa, FL - August 8, 2025 - SafeHeal, a leading innovator in the field of colorectal cancer surgery, today announced that it has been granted Europ
Read more
Report
Press release 1 year ago
SafeHeal Closes Oversubscribed €35 Million Series C Equity Financing
SafeHeal announces the successful completion of an oversubscribed €35 million Series C equity financing to validate the use of Colovac, a groundbreaking temporary endoluminal fecal bypass system.
Read more
Report
Show more news

Offices

Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
2
Loading the map
Headquarters Builds here Office with open vacancies No open vacancies right now Tap a pin for the office
Paris France
Regional office
SafeHeal SAS
40 rue du Louvre, 75001 Paris — France
company site
Tampa United States
Regional office
Please fill in the contact form below and we will be happy to assist you.
1501 W. Cleveland Street, Suite 210, Tampa, FL 33606 — United States
company site

Financials

Total raised
$45.2M
Latest round
Series C
Funding rounds
2
Funding rounds
Round Announced Amount
Series C 2025 $37.8M Details
Series A 2018 $7.4M Details